State Street’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,073
Closed -$597K 4312
2025
Q1
$597K Sell
26,073
-50,297
-66% -$1.21M ﹤0.01% 3549
2024
Q4
$1.93M Sell
76,370
-80
-0.1% -$2.03K ﹤0.01% 3331
2024
Q3
$1.91M Hold
76,450
﹤0.01% 3344
2024
Q2
$2.27M Sell
76,450
-157,768
-67% -$4.38M ﹤0.01% 3280
2024
Q1
$7.06M Sell
234,218
-30,050
-11% -$834K ﹤0.01% 2767
2023
Q4
$7.56M Buy
264,268
+5,753
+2% +$169K ﹤0.01% 2737
2023
Q3
$9.58M Sell
258,515
-809
-0.3% -$30.9K ﹤0.01% 2624
2023
Q2
$10.1M Sell
259,324
-2,168
-0.8% -$85K ﹤0.01% 2641
2023
Q1
$9.55M Sell
261,492
-23,943
-8% -$756K ﹤0.01% 2686
2022
Q4
$8.79M Buy
+285,435
New +$8.86M ﹤0.01% 2776

Other funds holding RTO

State Street's RTO Position: Q2 2025 in Review

State Street sold out of Rentokil (RTO) in Q2 2025, closing a stake of 26,073 shares — an estimated $597K sold.

State Street first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $10.1M in Q2 2023. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • State Street reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • State Street sold 26,073 Rentokil shares in Q2 2025, an estimated $597K.
  • State Street first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • State Street's Rentokil position peaked at $10.1M in Q2 2023.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.